Globenewswire
Search documents
Electra Approves Construction Budget and Sets Schedule for Completion of its North American Cobalt Sulfate Refinery
Globenewswire· 2026-02-23 12:00
(All amounts in US$ unless otherwise stated) TORONTO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) today announced that its Board of Directors has approved a $73 million construction budget and established an execution schedule to achieve mechanical completion of its cobalt sulfate Refinery north of Toronto, marking a significant step toward bringing North America’s first battery-grade cobalt refinery into operation. Commiss ...
Plug To Announce 2025 Fourth Quarter and Year-End Results
Globenewswire· 2026-02-23 12:00
SLINGERLANDS, N.Y., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, will announce its 2025 fourth quarter and year-end results on March 2, 2026. Join the call: Date: March 2, 2026Time: 4:30 PM ETToll-free: 877-407-9221 / +1 201-689-8597Direct webcast: https://event.webcasts.com/starthere.jsp?ei=1751318&tp_key=e18033c0ef The webcast can also be accessed directly from the Plug homepage (www.plugpower.com). A playba ...
TDG Discovers New ‘4300 Zone’ VMS Lens Below Former Hidden Creek Mine at Anyox Project
Globenewswire· 2026-02-23 12:00
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TDG Gold Corp. (TSXV: TDG | OTCQX: TDGGF) (the “Company” or “TDG”) is pleased to announce the discovery of a new lens (4300 Zone) of volcanogenic massive sulphide (“VMS”) Cu-Zn-Au-Ag-Co1 mineralization located below the past producing Hidden Creek Mine, at its 100% owned Anyox Project located, in the Golden Horseshoe of British Columbia. The Hidden Creek Mine was discovered in 1901 and operated between 1914-1935, with reported historical product ...
C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
Globenewswire· 2026-02-23 12:00
Enrollment for Phase 2 MOMENTUM Trial Expected to Be Completed in Q1 2027 Phase 1b Trial of Cemsidomide in Combination with Elranatamab on Track to Initiate in Q2 2026 WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that the first patient has been dosed in the Phase 2 MOMENTUM trial evaluating cemsidomide in combination with dexamethasone fo ...
Loblaw to invest $2.4 billion in the Canadian economy in 2026, with plans to build 70 new stores and create well over 9,000 jobs
Globenewswire· 2026-02-23 12:00
The investment is part of a 5-year plan to invest $10 billion in Canadian communities by 2030BRAMPTON, Ontario, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Today, Loblaw Companies Limited (TSX: L, “Loblaw” or the “Company”), Canada’s food and pharmacy leader, announced that it will spend $2.4 billion in 2026 to expand and renovate its store network, enhance its supply chain capabilities, and create jobs for people all across Canada. At a time when Canadians are struggling with affordability and access to healthcare s ...
Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference
Globenewswire· 2026-02-23 12:00
WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in a webcast fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 9:50 a.m. ET. The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 30 days following the event. About Apelli ...
Ocular Therapeutix™ to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations
Globenewswire· 2026-02-23 12:00
Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to host an investor webcast on Monday, March 2, 2026, at 7:30 AM ET to discuss the Macula Society presentations BEDFORD, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the Company will present detailed re ...
illumin Holdings Inc. announces date for Fourth Quarter and Year-End 2025 Financial and Operating Results
Globenewswire· 2026-02-23 12:00
TORONTO and NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX:ILLM, OTCQB:ILLMF) (“illumin” or “Company”), a leader in digital advertising technology that empowers marketers to make smarter decisions about communicating with online consumers, announces that it will report its fourth quarter and year-end 2025 financial results before market open on Friday, March 13, 2026. Investors and analysts are invited to join a live webcast on Friday, March 13, 2026, at 8:30 AM ET, where CEO Simon C ...
Winnebago Industries to Participate in Fireside Chat at the Raymond James 2026 Institutional Investors Conference
Globenewswire· 2026-02-23 12:00
EDEN PRAIRIE, Minn, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE: WGO), a leading manufacturer of outdoor recreation products, today announced that Senior Vice President and Chief Financial Officer Bryan Hughes and Joan Ondala, Vice President, Treasury and Investor Relations, will participate in an analyst‑led fireside chat and conduct one‑on‑one meetings at the Raymond James 2026 Institutional Investors Conference in Orlando, Florida. The fireside chat will take place on Monday, March ...
Signify share repurchase periodic update
Globenewswire· 2026-02-23 12:00
Press Release February 23, 2026 Signify share repurchase periodic update Eindhoven, The Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has repurchased 139,500 shares in the period February 13 to February 20, 2026. The shares were repurchased at an average price of EUR 20.06 per share and an aggregate amount of EUR 2.8 million. The repurchases were made as part of the company’s share repurchase program, which was announced on 13 February 2026. Details on the ...